Search Results - "Finch, Emily R."

Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone treated mice by Finch, Emily R, Payton, Monique A, Jenkins, David A, Cai, Xiangjun, Li, Lie, Karol, Seth E, Relling, Mary V, Janke, Laura J

“…Recent clinical trials in children with acute lymphoblastic leukemia (ALL) indicate that severe hypertriglyceridemia (> 1000 mg/dL) during therapy is…”
Get full text

Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells by Qian, Fenghua, Nettleford, Shaneice K., Zhou, Jiayan, Arner, Brooke E., Hall, Molly A., Sharma, Arati, Annageldiyev, Charyguly, Rossi, Randy M., Tukaramrao, Diwakar B., Sarkar, Deborpita, Hegde, Shailaja, Gandhi, Ujjawal H., Finch, Emily R., Goodfield, Laura, Quickel, Michael D., Claxton, David F., Paulson, Robert F., Prabhu, K. Sandeep

“…Relapse of acute myeloid leukemia (AML) remains a significant concern due to persistent leukemia-initiating stem cells (LICs) that are typically not targeted…”
Get full text

Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy by Karol, Seth E, Pei, Deqing, Smith, Colton A, Liu, Yiwei, Yang, Wenjian, Kornegay, Nancy M, Panetta, John C, Crews, Kristine R, Cheng, Cheng, Finch, Emily R, Inaba, Hiroto, Metzger, Monika L, Rubnitz, Jeffrey E, Ribeiro, Raul C, Gruber, Tanja A, Yang, Jun J, Evans, William E, Jeha, Sima, Pui, Ching-Hon, Relling, Mary V

“…Chemotherapy dosages are often compromised, but most reports lack data on dosages that are actually delivered. In two consecutive acute lymphoblastic leukemia…”
Get full text

Distinct DNA methylation signatures associated with blood lipids as exposures or outcomes among survivors of childhood cancer: a report from the St. Jude lifetime cohort by Dong, Qian, Chen, Cheng, Song, Nan, Qin, Na, Plonski, Noel-Marie, Finch, Emily R, Shelton, Kyla, Easton, John, Mulder, Heather, Plyer, Emily, Neale, Geoffrey, Walker, Emily, Li, Qian, Huang, I-Chan, Zhang, Jinghui, Wang, Hui, Hudson, Melissa M, Robison, Leslie L, Ness, Kirsten K, Wang, Zhaoming

“…DNA methylation (DNAm) plays an important role in lipid metabolism, however, no epigenome-wide association study (EWAS) of lipid levels has been conducted…”
Get full text

Physical activity and fitness in childhood cancer survivors: A scoping review by Wogksch, Matthew D., Goodenough, Chelsea G., Finch, Emily R., Partin, Robyn E., Ness, Kirsten K.

“…Background Estimates indicate that nearly 8% of the over 500,000 survivors of childhood cancer living in the United States are frail in their fourth and fifth…”
Get full text

Energy cost of walking in obese survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort by Wogksch, Matthew D, Finch, Emily R, Nolan, Vikki G, Smeltzer, Matthew P, Mzayek, Fawaz, Goodenough, Chelsea G, Pui, Ching-Hon, Inaba, Hiroto, Mulrooney, Daniel A, Kaste, Sue C, Brinkman, Tara M, Lanctot, Jennifer Q, Srivastava, Deo Kumar, Jefferies, John L, Armstrong, Gregory T, Robison, Leslie L, Hudson, Melissa M, Ness, Kirsten K

“…Adult survivors of childhood acute lymphoblastic leukemia (ALL) have impaired adaptive physical function and poor health-related quality of life (HRQoL)…”
Get full text

Activation of PPARγ by endogenous prostaglandin J2 mediates the antileukemic effect of selenium in murine leukemia by Finch, Emily R., Tukaramrao, Diwakar B., Goodfield, Laura L., Quickel, Michael D., Paulson, Robert F., Prabhu, K.Sandeep

“…Supplementation with nontoxic doses of micronutrient selenium has been shown to alleviate chronic myelogenous leukemia (CML) via the elimination of leukemia…”
Get full text

Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia by Finch, Emily R., Smith, Colton A., Yang, Wenjian, Liu, Yiwei, Kornegay, Nancy M., Panetta, John C., Crews, Kristine R., Molinelli, Alejandro R., Cheng, Cheng, Pei, Deqing, Ramsey, Laura B., Karol, Seth E., Inaba, Hiroto, Sandlund, John T., Metzger, Monika, Evans, William E., Jeha, Sima, Pui, Ching‐Hon, Relling, Mary V.

“…Background Glucocorticoids and asparaginase, used to treat acute lymphoblastic leukemia (ALL), can cause hypertriglyceridemia. We compared triglyceride levels,…”
Get full text

Association between CEP72 genotype and persistent neuropathy in survivors of childhood acute lymphoblastic leukemia by Goodenough, Chelsea G., Diouf, Barthelemy, Yang, Wenjian, Sapkota, Yadav, Finch, Emily R., Lu, Lu, Partin, Robyn E., Wogksch, Matthew D., Hudson, Melissa M., Robison, Leslie L., Wang, Zhaoming, Jeha, Sima, Evans, William E., Ness, Kirsten K.

Get full text

Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical models by Janke, Laura J., Kim, Jieun, Payton, Monique A., Jenkins, David A., Cai, Xiangjun, Finch, Emily R., Liu, Yiwei, Relling, Mary V., Karol, Seth E.

“…Background Osteonecrosis is a devastating side effect of acute lymphoblastic leukemia (ALL) therapy. Associations between bone density loss and osteonecrosis…”
Get full text

Dasatinib does not exacerbate dexamethasone‐induced osteonecrosis in murine models of acute lymphoblastic leukemia therapy by Finch, Emily R., Janke, Laura J., Li, Lie, Payton, Monique A., Jenkins, David A., Crews, Kristine R., Relling, Mary V., Karol, Seth E.

“…Introduction There are clinical reports that the incorporation of dasatinib may increase the frequency of osteonecrosis in acute lymphoblastic leukemia (ALL)…”
Get full text

Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid‐induced osteonecrosis by Finch, Emily R., Janke, Laura J., Smith, Colton A., Karol, Seth E., Pei, Deqing, Cheng, Cheng, Kaste, Sue C., Inaba, Hiroto, Pui, Ching‐Hon, Wolf, Joshua, Relling, Mary V.

“…Background Osteonecrosis is a common toxicity associated with glucocorticoid (e.g., dexamethasone and prednisone) treatment of children with acute…”
Get full text

Selenium Suppresses Leukemia through the Action of Endogenous Eicosanoids by GANDHI, Ujjawal H, KAUSHAL, Naveen, HEGDE, Shailaja, FINCH, Emily R, KUDVA, Avinash K, KENNETT, Mary J, JORDAN, Craig T, PAULSON, Robert F, SANDEEP PRABHU, K

“…Eradicating cancer stem-like cells (CSC) may be essential to fully eradicate cancer. Metabolic changes in CSC could hold a key to their targeting. Here, we…”
Get full text

Race and Ethnicity, Socioeconomic Factors, and Epigenetic Age Acceleration in Survivors of Childhood Cancer by Chen, Cheng, Plonski, Noel-Marie, Dong, Qian, Song, Nan, Zhang, Xijun, Parikh, Hemang M, Finch, Emily R, Easton, John, Mulder, Heather L, Walker, Emily, Neale, Geoffrey, Pan, Yue, Li, Qian, Zhang, Jinghui, Krull, Kevin, Robison, Leslie L, Armstrong, Gregory T, Yasui, Yutaka, Ness, Kirsten K, Hudson, Melissa M, Wang, Hui, Huang, I-Chan, Wang, Zhaoming

“…Current research in epigenetic age acceleration (EAA) is limited to non-Hispanic White individuals. It is imperative to improve inclusivity by considering…”
Get full text

Epigenetic Age in Peripheral Blood Among Children, Adolescent, and Adult Survivors of Childhood Cancer by Plonski, Noel-Marie, Chen, Cheng, Dong, Qian, Qin, Na, Song, Nan, Parikh, Hemang M, Shelton, Kyla, Finch, Emily R, Easton, John, Mulder, Heather, Zhang, Jinghui, Neale, Geoffrey, Walker, Emily, Wang, Hui, Krull, Kevin, Ness, Kirsten K, Hudson, Melissa M, Robison, Leslie L, Li, Qian, Williams, AnnaLynn, Wang, Zhaoming

“…Certain cancer therapies are risk factors for epigenetic age acceleration (EAA) among survivors of childhood cancer, and EAA is associated with chronic health…”
Get full text

Chemopreventive Effects of Dietary Eicosapentaenoic Acid Supplementation in Experimental Myeloid Leukemia by Finch, Emily R, Kudva, Avinash K, Quickel, Michael D, Goodfield, Laura L, Kennett, Mary J, Whelan, Jay, Paulson, Robert F, Prabhu, K Sandeep

“…Current therapies for treatment of myeloid leukemia do not eliminate leukemia stem cells (LSC), leading to disease relapse. In this study, we supplemented mice…”
Get full text

Physical performance limitations and participation restrictions among cancer survivors: A population-based study from NHANES data 2015-2018 by Myers, Samantha A., Finch, Emily R, Ness, Kirsten K., Campbell, Kristin L.

“…12096 Background: Anti-cancer therapies have improved survival outcomes in cancer survivors; however, therapy-related toxicities may impact organ structure and…”
Get full text

Associations between diet quality and chronic health conditions (CHCs) in adult survivors of childhood cancer in the St. Jude Lifetime Cohort Study (SJLIFE) by Finch, Emily R, Foley, Elizabeth, Hyun, Geehong, Goodenough, Chelsea Goodliffe, Zhang, Fang Fang, Krull, Kevin R., Bhakta, Nickhill, Park, Yikyung, Ehrhardt, Matthew J., Brinkman, Tara M., Lanctot, Jennifer Q., Robison, Leslie L., Hudson, Melissa M., Ness, Kirsten K.

“…12095 Background: Survivors of childhood cancer are at increased risk for early development of CHCs, including metabolic syndrome (MetS), low bone mineral…”
Get full text

Protein, fat, and animal food intakes and premature aging in adult survivors of childhood cancer: St. Jude Lifetime (SJLIFE) cohort by Park, Yikyung, Williams, AnnaLynn, Finch, Emily R, Lanctot, Jennifer Q., Jiang, Shu, Krull, Kevin R., Armstrong, Gregory T., Hudson, Melissa M., Colditz, Graham A., Robison, Leslie L., Ness, Kirsten K.

“…10055 Background: Childhood cancer survivors are a growing population who appear to be at higher risk for premature aging and age-related chronic health…”
Get full text

The Effect of Asparaginase on Serum Triglycerides during Therapy for Acute Lymphoblastic Leukemia by Finch, Emily R, Smith, Colton A, Yang, Wenjian, Kornegay, Nancy M, Panetta, John C, Crews, Kristine R, Molinelli, Alejandro R, Cheng, Cheng, Pei, Deqing, Ramsey, Laura B., Karol, Seth E, Inaba, Hiroto, Sandlund, John T., Metzger, Monika, Evans, William E., Jeha, Sima, Pui, Ching-Hon, Relling, Mary V

“…Introduction: Treatment for acute lymphoblastic leukemia (ALL) with asparaginase (ASP) and glucocorticoids, such as dexamethasone (DEX), can cause changes in…”
Get full text